AB1668-PARE IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES THROUGH 6 MONTHS OF GUSELKUMAB TREATMENT IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: REAL-WORLD DATA FROM THE COREVITAS PSORIATIC ARTHRITIS/SPONDYLOARTHRITIS REGISTRY
Annals of the Rheumatic Diseases(2024)
Key words
Pain,Disease-modifying Drugs (DMARDs),Observational studies/ registry,Patient Reported Outcome Measures,Real-world evidence
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined